Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (20272)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 7, 2017 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D. Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments. World J Gastroenterol 2017; 23(33): 6030-6048 [PMID: 28970719 DOI: 10.3748/wjg.v23.i33.6030] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v23/i33/6030.htm |
| Number | Citing Articles |
| 1 |
Guiqiang Wang, Atsushi Tanaka, Hong Zhao, Jidong Jia, Xiong Ma, Kenichi Harada, Fu-Sheng Wang, Lai Wei, Qixia Wang, Ying Sun, Yuan Hong, Huiying Rao, Cumali Efe, George Lau, Diana Payawal, Rino Gani, Keith Lindor, Wasim Jafri, Masao Omata, Shiv Kumar Sarin. The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis. Hepatology International 2021; 15(2): 223 doi: 10.1007/s12072-021-10170-1
|
| 2 |
Julie R Brahmer, Hamzah Abu-Sbeih, Paolo Antonio Ascierto, Jill Brufsky, Laura C Cappelli, Frank B Cortazar, David E Gerber, Lamya Hamad, Eric Hansen, Douglas B Johnson, Mario E Lacouture, Gregory A Masters, Jarushka Naidoo, Michele Nanni, Miguel-Angel Perales, Igor Puzanov, Bianca D Santomasso, Satish P Shanbhag, Rajeev Sharma, Dimitra Skondra, Jeffrey A Sosman, Michelle Turner, Marc S Ernstoff. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events. Journal for ImmunoTherapy of Cancer 2021; 9(6): e002435 doi: 10.1136/jitc-2021-002435
|
| 3 |
Akshaya Ramachandran, Drashti Antala , Prasun Pudasainee, Sreelakshmi Panginikkod, Harsh Gupta. A Plausible Association Between the Use of Elderberry and Autoimmune Hepatitis. Cureus 2022; doi: 10.7759/cureus.24250
|
| 4 |
Richard Taubert, Katharina Luise Hupa-Breier, Elmar Jaeckel, Michael P. Manns. Novel therapeutic targets in autoimmune hepatitis. Journal of Autoimmunity 2018; 95: 34 doi: 10.1016/j.jaut.2018.10.022
|
| 5 |
Shahram Golbabapour, Kamran Bagheri-Lankarani, Saeid Ghavami, Bita Geramizadeh. Autoimmune Hepatitis and Stellate Cells: An Insight into the Role of Autophagy. Current Medicinal Chemistry 2020; 27(35): 6073 doi: 10.2174/0929867326666190402120231
|
| 6 |
Claudia Sîrbe, Alina Grama, Ancuţa Cutaş, Gabriel Benţa, Mara Puiu, Diana-Alexandra Borcău, Bianca Mariş, Simona Rednic, Tudor Lucian Pop. Treatment and outcomes of autoimmune hepatitis in children. Pediatru.ro 2022; 3(67): 28 doi: 10.26416/Pedi.67.3.2022.7236
|
| 7 |
Yingzhou Shi, Hang Dong, Shiwei Sun, Xiaoqin Wu, Jiansong Fang, Jianbo Zhao, Junming Han, Zongyue Li, Huixiao Wu, Luna Liu, Wanhong Wu, Yang Tian, Guandou Yuan, Xiude Fan, Chao Xu. Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets. Clinical and Molecular Hepatology 2023; 30(1): 80 doi: 10.3350/cmh.2023.0343
|
| 8 |
Zhen-Jun Yu, Lu-Lu Zhang, Ting-Ting Huang, Jian-Sheng Zhu, Ze-Bao He. Comparison of mycophenolate mofetil with standard treatment for autoimmune hepatitis: a meta-analysis. European Journal of Gastroenterology & Hepatology 2019; 31(7): 873 doi: 10.1097/MEG.0000000000001367
|
| 9 |
Matthias Buechter, Dominik Dorn, Birte Möhlendick, Winfried Siffert, Hideo A. Baba, Guido Gerken, Alisan Kahraman. Characteristics and Long-Term Outcome of 535 Patients with Autoimmune Hepatitis—The 20-Year Experience of a High-Volume Tertiary Center. Journal of Clinical Medicine 2023; 12(13): 4192 doi: 10.3390/jcm12134192
|
| 10 |
Hao Zhou, Qing Ye. Clinical Features of COVID-19 Vaccine-Associated Autoimmune Hepatitis: A Systematic Review. Diseases 2023; 11(2): 80 doi: 10.3390/diseases11020080
|
| 11 |
Chrong-Reen Wang, Hung-Wen Tsai. Autoimmune liver diseases in systemic rheumatic diseases. World Journal of Gastroenterology 2022; 28(23): 2527-2545 doi: 10.3748/wjg.v28.i23.2527
|
| 12 |
Tarek A. Tamimi, Malik Sallam, Deema Rayyan, Randa Farah, Dana Alkhulaifat, Abdallah Al-Ani, Reem Elmusa, Said Sharawi, Omar Tanash, Yaser Rayyan. Clinical Characteristics of Autoimmune Hepatitis in a Middle Eastern Population: A Tertiary Care Center Experience. Journal of Clinical Medicine 2023; 12(2): 629 doi: 10.3390/jcm12020629
|
| 13 |
Natanie J. Anilovich. Oral budesonide is an effective alternative to prednisone for treatment of autoimmune hepatitis. Clinical Research In Practice: The Journal of Team Hippocrates 2021; 7(2) doi: 10.22237/crp/1622160960
|
| 14 |
Saumya Pathak, Deepak Kamat. Autoimmune Hepatitis in Children. Pediatric Annals 2018; 47(2) doi: 10.3928/19382359-20180126-01
|
| 15 |
Erasmo Miele, Marc A. Benninga, Ilse Broekaert, Jernej Dolinsek, Emmanuel Mas, Rok Orel, Corina Pienar, Carmen Ribes‐Koninckx, Rut A. Thomassen, Mike Thomson, Christos Tzivinikos, Nikhil Thapar. Safety of Thiopurine Use in Paediatric Gastrointestinal Disease. Journal of Pediatric Gastroenterology and Nutrition 2020; 71(2): 156 doi: 10.1097/MPG.0000000000002802
|
| 16 |
Ruben De Wilde, Michael Saerens, Anne Hoorens, Anja Geerts, Celine Jacobs. Treatment of Refractory Checkpoint-Inhibitor-Induced Hepatitis with Tacrolimus: A Case and Review of the Literature. International Journal of Translational Medicine 2023; 3(3): 274 doi: 10.3390/ijtm3030019
|
| 17 |
Jun Liu, Tingting Shen, Long Li, Xingyi Li, Fang Zhao, Xiaoxia Liu, Shan Zhang, Pengjia Wu, Na Li, Jiashun Zeng. A systemic lupus erythematosus patient with persistent elevated conjugated bilirubin as the initial symptom: A case report. Medicine 2024; 103(6): e36999 doi: 10.1097/MD.0000000000036999
|
| 18 |
Marilena Durazzo, Giulia Lupi, Michela Scandella, Arianna Ferro, Gabriella Gruden. Autoimmune hepatitis treatment in the elderly: A systematic review. World Journal of Gastroenterology 2019; 25(22): 2809-2818 doi: 10.3748/wjg.v25.i22.2809
|
| 19 |
Angelo Del Gaudio, Federica Di Vincenzo, Valentina Petito, Maria Cristina Giustiniani, Antonio Gasbarrini, Franco Scaldaferri, Loris Riccardo Lopetuso. Focus on Immune Checkpoint Inhibitors-related Intestinal Inflammation: From Pathogenesis to Therapeutical Approach. Inflammatory Bowel Diseases 2023; doi: 10.1093/ibd/izad229
|
| 20 |
Pinelopi Arvaniti, Ignasi Olivas, Sergio Rodriguez-Tajes, George N. Dalekos, Maria-Carlota Londoño. Second- and third-line treatment agents in autoimmune hepatitis (AIH): Where do we stand?. Exploration of Digestive Diseases 2024; : 92 doi: 10.37349/edd.2024.00042
|
| 21 |
Daniel D’Agostino, Maria Camila Sanchez, Gustavo Boldrini. Pediatric Hepatology and Liver Transplantation. 2019; : 687 doi: 10.1007/978-3-319-96400-3_39
|
| 22 |
I. M. Iljinsky, O. M. Tsirulnikova. Historical aspects and current understanding of autoimmune hepatitis. When is liver transplantation indicated? (Review). Russian Journal of Transplantology and Artificial Organs 2022; 24(2): 39 doi: 10.15825/1995-1191-2022-2-39-50
|
| 23 |
Artur Świerczek, Hanna Plutecka, Marietta Ślusarczyk, Grażyna Chłoń-Rzepa, Elżbieta Wyska. PK/PD Modeling of the PDE7 Inhibitor—GRMS-55 in a Mouse Model of Autoimmune Hepatitis. Pharmaceutics 2021; 13(5): 597 doi: 10.3390/pharmaceutics13050597
|
| 24 |
Betul Aksoy, Masallah Baran, Yeliz Cagan Appak, Elif Sag, Murat Cakir, Burcu Guven, Sibel Yavuz, Busra Emir, Gokhan Tumgor. Efficiency of azathioprine monotherapy for maintenance treatment of autoimmune hepatitis in children. European Journal of Gastroenterology & Hepatology 2022; 34(1): 92 doi: 10.1097/MEG.0000000000001930
|
| 25 |
Christina G. Plagiannakos, Gideon M. Hirschfield, Ellina Lytvyak, Surain B. Roberts, Marwa Ismail, Aliya F. Gulamhusein, Nazia Selzner, Karim M. Qumosani, Lawrence Worobetz, Julian Hercun, Catherine Vincent, Jennifer A. Flemming, Mark G. Swain, Angela Cheung, Tianyan Chen, Dusanka Grbic, Kevork Peltekain, Andrew L. Mason, Aldo J. Montano-Loza, Bettina E. Hansen. Treatment response and clinical event-free survival in autoimmune hepatitis: a Canadian multicentre cohort study. Journal of Hepatology 2024; doi: 10.1016/j.jhep.2024.03.021
|
| 26 |
Diego Vergani, Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani. A reasoned approach to the treatment of autoimmune hepatitis. Digestive and Liver Disease 2021; 53(11): 1381 doi: 10.1016/j.dld.2021.05.033
|
| 27 |
Haiyan Fu, Yingchao Li, Gelan Bai, Runkai Yin, Chunlan Yin, Weina Shi, Lili Zhang, Rongpin Li, Ruiqin Zhao. Persistent cholestasis resulting from duodenal papillary carcinoma in an adolescent male. Medicine 2019; 98(22): e15708 doi: 10.1097/MD.0000000000015708
|
| 28 |
Mamta Bajre, Mina Moawad, Elizabeth Shumbayawonda, Jane Elizabeth Carolan, Julie Hart, Emma Culver, Michael Heneghan. LiverMultiScan as an alternative to liver biopsy to monitor autoimmune hepatitis in the National Health Service in England: an economic evaluation. BMJ Open 2022; 12(9): e058999 doi: 10.1136/bmjopen-2021-058999
|
| 29 |
Michael A. Heneghan, Elizabeth Shumbayawonda, Andrea Dennis, Refah Z. Ahmed, Mussarat N. Rahim, Michael Ney, Loren Smith, Matt Kelly, Rajarshi Banerjee, Emma L. Culver. Quantitative magnetic resonance imaging to aid clinical decision making in autoimmune hepatitis. eClinicalMedicine 2022; 46: 101325 doi: 10.1016/j.eclinm.2022.101325
|
| 30 |
Rithika Bhat, Antonio Tonutti, Suraj Timilsina, Carlo Selmi, M. Eric Gershwin. Perspectives on Mycophenolate Mofetil in the Management of Autoimmunity. Clinical Reviews in Allergy & Immunology 2023; 65(1): 86 doi: 10.1007/s12016-023-08963-3
|
| 31 |
Marcos Mucenic. Advancements in autoimmune hepatitis management: Perspectives for future guidelines. World Journal of Hepatology 2024; 16(2): 135-139 doi: 10.4254/wjh.v16.i2.135
Abstract(97) |
Core Tip(91) |
Full Article(HTML)(704)
|
Full Article with Cover (PDF)-874K(32)
|
Full Article (Word)-115K(8)
|
Audio-286K(0)
|
Peer-Review Report-180K(7)
|
Answering Reviewers-52K(8)
|
Full Article (PDF)-363K(31)
|
Full Article (XML)-68K(11)
|
Times Cited (0)
|
Total Visits (1238)
|
Open
|
| 32 |
Hyun Goo Kang, Heesun Park, Ga Eun Myong, Woo Jeong Kim, Chae Eun Mun, Chae Rin Kim, Chae Yeon You, Su Kang Kim, Min Su Park, Sang-il Park. Beneficial Effect of Rapamycin on Liver Fibrosis in a Mouse Model (C57bl/6 Mouse). Transplantation Proceedings 2024; doi: 10.1016/j.transproceed.2024.03.001
|
| 33 |
Tarini Ullal, Yoko Ambrosini, Sangeeta Rao, Cynthia R. L. Webster, David Twedt. Retrospective evaluation of cyclosporine in the treatment of presumed idiopathic chronic hepatitis in dogs. Journal of Veterinary Internal Medicine 2019; 33(5): 2046 doi: 10.1111/jvim.15591
|
| 34 |
Tuğçe ÇAĞLAR, Azar ABİYEV, Özlem ERDEM, Murat KEKİLLİ, İbrahim DOĞAN. Otoimmün hepatit tanılı hastada azatioprin tedavisi sonrası gelişen Kaposi sarkomu. Akademik Gastroenteroloji Dergisi 2021; 20(2): 123 doi: 10.17941/agd.978336
|
| 35 |
Yooyun Chung, Mussarat N Rahim, Jonathon J Graham, Yoh Zen, Michael A Heneghan. An update on the pharmacological management of autoimmune hepatitis. Expert Opinion on Pharmacotherapy 2021; 22(11): 1475 doi: 10.1080/14656566.2021.1895747
|
| 36 |
Fares E.M. Ali, Mustafa Ahmed Abdel-Reheim, Emad H.M. Hassanein, Mostafa K. Abd El-Aziz, Hanan S. Althagafy, Khalid S.A. Badran. Exploring the potential of drug repurposing for liver diseases: A comprehensive study. Life Sciences 2024; : 122642 doi: 10.1016/j.lfs.2024.122642
|
| 37 |
Benedetta Terziroli Beretta-Piccoli, Diego Vergani, Giorgina Mieli-Vergani. Autoimmune sclerosing cholangitis: Evidence and open questions. Journal of Autoimmunity 2018; 95: 15 doi: 10.1016/j.jaut.2018.10.008
|
| 38 |
Hydar El Jamaly, Guy D. Eslick, Martin Weltman. Systematic review with meta-analysis: autoimmune hepatitis in pregnancy. Scandinavian Journal of Gastroenterology 2021; 56(10): 1194 doi: 10.1080/00365521.2021.1953127
|
| 39 |
Kenneth W. Chow, Nguyen V. Pham, Britney M. Ibrahim, Kimberly Hong, Sammy Saab. Autoimmune Hepatitis-Like Syndrome Following COVID-19 Vaccination: A Systematic Review of the Literature. Digestive Diseases and Sciences 2022; 67(9): 4574 doi: 10.1007/s10620-022-07504-w
|
| 40 |
Elisabeth Sucher, Robert Sucher, Tanja Gradistanac, Gerald Brandacher, Stefan Schneeberger, Thomas Berg. Autoimmune Hepatitis—Immunologically Triggered Liver Pathogenesis—Diagnostic and Therapeutic Strategies. Journal of Immunology Research 2019; 2019: 1 doi: 10.1155/2019/9437043
|
| 41 |
Keaton R. Jones, Craig S. Lammert. Management of Autoimmune Hepatitis Patients Refractory to or Intolerant of Standard Therapies. Current Hepatology Reports 2018; 17(3): 166 doi: 10.1007/s11901-018-0401-2
|
| 42 |
Giulia Jannone, Isabelle Scheers, Françoise Smets, Xavier Stephenne, Etienne M Sokal. Everolimus is Safe as a Second-/Third-Line Therapy in Pediatric Autoimmune Hepatitis. JPGN Reports 2022; 3(3): e227 doi: 10.1097/PG9.0000000000000227
|
| 43 |
Simon Pape, Christoph Schramm, Tom JG Gevers. Clinical management of autoimmune hepatitis. United European Gastroenterology Journal 2019; 7(9): 1156 doi: 10.1177/2050640619872408
|
| 44 |
Yi Dong, Andrej Potthoff, Christoph Klinger, Ana Paula Barreiros, Dariusz Pietrawski, Christoph F Dietrich. Ultrasound findings in autoimmune hepatitis. World Journal of Gastroenterology 2018; 24(15): 1583-1590 doi: 10.3748/wjg.v24.i15.1583
|
| 45 |
Benedetta Terziroli Beretta-Piccoli, Gustav Buescher, George Dalekos, Kalliopi Zachou, Anja Geerts, Nasser Semmo, Mirjam Kolev, Eleonora De Martin, Maciej K. Janik, João Madaleno, Milica Lalosevic Stojkovic, Jérôme Dumortier, Thomas Vanwolleghem, Ida Schregel, Silja Steinmann, Florence Lacaille, Marcial Sebode. Hepatic safety and efficacy of immunomodulatory drugs used in patients with autoimmune hepatitis. Journal of Autoimmunity 2023; 140: 103113 doi: 10.1016/j.jaut.2023.103113
|
| 46 |
Richard L. Pullen, Patricia Francis-Johnson. Inside autoimmune liver disease. Nursing Made Incredibly Easy! 2019; 17(1): 40 doi: 10.1097/01.NME.0000549616.82525.47
|
| 47 |
Abel Vieira de Melo Bisneto, Amanda Silva Fernandes, Vivianne de Souza Velozo Sá, Jefferson Hollanda Véras, Estéfane Thaíne Sodré Soares, Aline Ferreira da Silva Santos, Clever Gomes Cardoso, Elisângela de Paula Silveira-Lacerda, Cristiene Costa Carneiro, Lee Chen-Chen. Anti-angiogenic activity of azathioprine. Microvascular Research 2021; 138: 104234 doi: 10.1016/j.mvr.2021.104234
|
| 48 |
Leonard Kaps, María José Limeres, Paul Schneider, Malin Svensson, Yanira Zeyn, Silvia Fraude, Maximiliano L. Cacicedo, Peter R. Galle, Stephan Gehring, Matthias Bros. Liver Cell Type-Specific Targeting by Nanoformulations for Therapeutic Applications. International Journal of Molecular Sciences 2023; 24(14): 11869 doi: 10.3390/ijms241411869
|
| 49 |
Cong Meng, Yu Liu, Yuping Ming, Cao Lu, Yanggege Li, Yulu Zhang, Dongdong Su, Xueyun Gao, Qing Yuan. Enhancing Liver Delivery of Gold Nanoclusters via Human Serum Albumin Encapsulation for Autoimmune Hepatitis Alleviation. Pharmaceutics 2024; 16(1): 110 doi: 10.3390/pharmaceutics16010110
|
| 50 |
Parth Shah, Vinay Sundaram, Einar Björnsson. Biologic and Checkpoint Inhibitor‐Induced Liver Injury: A Systematic Literature Review. Hepatology Communications 2020; 4(2): 172 doi: 10.1002/hep4.1465
|
| 51 |
Thomas Lung, Benjamin Sakem, Lorenz Risch, Reinhard Würzner, Giuseppe Colucci, Andreas Cerny, Urs Nydegger. The complement system in liver diseases: Evidence-based approach and therapeutic options. Journal of Translational Autoimmunity 2019; 2: 100017 doi: 10.1016/j.jtauto.2019.100017
|
| 52 |
Paul A. Schmeltzer. Diagnosis and Management of Autoimmune Hepatitis. 2020; : 93 doi: 10.1007/978-3-030-33628-8_6
|
| 53 |
Haoran Chen, Zhongyu Han, Yiyue Fan, Liuyan Chen, Fang Peng, Xuhua Cheng, Yi Wang, Junyan Su, Dongxuan Li. CD4+ T-cell subsets in autoimmune hepatitis: A review. Hepatology Communications 2023; 7(10) doi: 10.1097/HC9.0000000000000269
|
| 54 |
Lydia T de Moraes Falcão, Debora R B Terrabuio, Marcio A Diniz, Andreia da Silva Evangelista, Fabricio G Souza, Eduardo L R Cancado. Efficacy and safety of chloroquine plus prednisone for the treatment of autoimmune hepatitis in a randomized trial. JGH Open 2020; 4(3): 371 doi: 10.1002/jgh3.12258
|
| 55 |
Kamil Janowski, Elizabeth Shumbayawonda, Lin Cheng, Caitlin Langford, Andrea Dennis, Matt Kelly, Maciej Pronicki, Wieslawa Grajkowska, Malgorzata Wozniak, Piotr Pawliszak, Sylwia Chełstowska, Elzbieta Jurkiewicz, Rajarshi Banerjee, Piotr Socha. Quantitative multiparametric MRI as a non-invasive stratification tool in children and adolescents with autoimmune liver disease. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-94754-9
|
| 56 |
Romée JALM Snijders, Piotr Milkiewicz, Christoph Schramm, Tom JG Gevers. Health-related quality of life in autoimmune hepatitis. World Journal of Hepatology 2021; 13(11): 1642-1652 doi: 10.4254/wjh.v13.i11.1642
|
| 57 |
Vikram K. Raghu, Robert H. Squires. Encyclopedia of Gastroenterology. 2020; : 444 doi: 10.1016/B978-0-12-801238-3.66040-3
|
| 58 |
Luana Cagol, Teresa Seitel, Sarah Ehrenberg, Klara Frivolt, Andreas Krahl, Elke Lainka, Patrick Gerner, Henning Lenhartz, Jan Vermehren, Michael Radke, Stefan Trenkel, Benjamin Mayer, Sibylle Koletzko, Klaus-Michael Debatin, Thomas Mertens, Carsten Posovszky. Vaccination rate and immunity of children and adolescents with inflammatory bowel disease or autoimmune hepatitis in Germany. Vaccine 2020; 38(7): 1810 doi: 10.1016/j.vaccine.2019.12.024
|
| 59 |
Sanjay Kalra, Saptarshi Bhattacharya, Pawan Rawal. Hepatocrinology. Medical Sciences 2021; 9(2): 39 doi: 10.3390/medsci9020039
|
| 60 |
玉兰 朱. Diagnosis and Treatment of Autoimmune Hepatitis-Primary Biliary Cholangitis Overlap Syndrome. Advances in Clinical Medicine 2023; 13(03): 4678 doi: 10.12677/ACM.2023.133671
|
| 61 |
Bridgette B. McNally, Elizabeth J. Carey. Azathioprine Monotherapy Is Equivalent to Dual Therapy in Maintaining Remission in Autoimmune Hepatitis. Digestive Diseases and Sciences 2021; 66(5): 1715 doi: 10.1007/s10620-020-06347-7
|
| 62 |
Carlo Mainetti, Benedetta Terziroli Beretta-Piccoli, Carlo Selmi. Cutaneous Manifestations of Dermatomyositis: a Comprehensive Review. Clinical Reviews in Allergy & Immunology 2017; 53(3): 337 doi: 10.1007/s12016-017-8652-1
|
| 63 |
KASL clinical practice guidelines for management of autoimmune hepatitis 2022. Clinical and Molecular Hepatology 2023; 29(3): 542 doi: 10.3350/cmh.2023.0087
|
| 64 |
Vincent Cheung, Tarun Gupta, Miranda Payne, Mark R Middleton, Jane D Collier, Alison Simmons, Paul Klenerman, Oliver Brain, Jeremy F Cobbold. Immunotherapy-related hepatitis: real-world experience from a tertiary centre. Frontline Gastroenterology 2019; 10(4): 364 doi: 10.1136/flgastro-2018-101146
|
| 65 |
Dan Wang, Kaniel Cassady, Zhongmin Zou, Xi Zhang, Yimei Feng. Progress on the efficacy and potential mechanisms of rapamycin in the treatment of immune thrombocytopenia. Hematology 2022; 27(1): 1282 doi: 10.1080/16078454.2022.2151230
|
| 66 |
Dieudonne Nonga, Maria Amendola, Jordan Serio, Mary Ayers, Amy Taylor, James E. Squires. Pediatric Autoimmune Hepatitis. Current Treatment Options in Pediatrics 2023; 9(3): 106 doi: 10.1007/s40746-023-00271-4
|
| 67 |
Looi C Ee. Liver disease in the older child. Journal of Paediatrics and Child Health 2020; 56(11): 1702 doi: 10.1111/jpc.14708
|
| 68 |
Simon Pape, Frederik Nevens, Chris Verslype, Caroline Mertens, Joost P.H. Drenth, Eric T.T.L. Tjwa. Profiling the patient with autoimmune hepatitis on calcineurin inhibitors: a real-world-experience. European Journal of Gastroenterology & Hepatology 2020; 32(6): 727 doi: 10.1097/MEG.0000000000001580
|
| 69 |
Artur Świerczek, Bartosz Pomierny, Elżbieta Wyska, William J. Jusko. Pharmacokinetic/Pharmacodynamic Assessment of Selective Phosphodiesterase Inhibitors in a Mouse Model of Autoimmune Hepatitis. Journal of Pharmacology and Experimental Therapeutics 2022; 381(2): 151 doi: 10.1124/jpet.121.001004
|
| 70 |
Bilger Çavuş, Filiz Akyuz, Raim İliaz, Alp Atasoy, Umit Akyuz, Kadir Demir, Fatih Besisik, Sabahattin Kaymakoglu. Is there any predictor for relapse after treatment withdrawal in autoimmune hepatitis patients in the real life?. International Journal of Immunopathology and Pharmacology 2022; 36: 039463202210778 doi: 10.1177/03946320221077860
|
| 71 |
Susan E. Fischer, Elsemieke S. de Vries, Maarten E. Tushuizen, Ynto S. de Boer, Adriaan J. P. van der Meer, Robert A. de Man, Johannes T. Brouwer, Johan P. Kuyvenhoven, Michael Klemt‐Kropp, Tom J. G. Gevers, Eric T. T. L. Tjwa, Edith M. M. Kuiper, Marc A. M. T. Verhagen, Philip W. Friederich, Bart van Hoek. Importance of complete response for outcomes of pregnancy in patients with autoimmune hepatitis. Liver International 2023; 43(4): 855 doi: 10.1111/liv.15511
|
| 72 |
Nitipat Sandusadee, Wattana Sukeepaisarnjaroen, Tanita Suttichaimongkol. Prognostic factors for remission, relapse, and treatment complications in type 1 autoimmune hepatitis. Heliyon 2020; 6(4): e03767 doi: 10.1016/j.heliyon.2020.e03767
|
| 73 |
Juliana Ximenes Damasceno, Maria Izabel Florindo Guedes, Christiane Araujo Chaves Leite, André Jalles Monteiro, Manasses Claudino Fonteles, Maria Esther Zurita Jimenez, Vilma de Lima, Thyciana Rodrigues Ribeiro, Cristiane Sá Roriz Fonteles. Salivary immunoglobulin levels in juvenile autoimmune hepatitis. Archives of Oral Biology 2018; 92: 51 doi: 10.1016/j.archoralbio.2018.04.014
|
| 74 |
Katerina Bakela, Maria Georgia Dimitraki, Evangelia Skoufa, Irene Athanassakis. Rescue of autoimmune hepatitis by soluble MHC class II molecules in an altered concanavalin A‐induced experimental model. Animal Models and Experimental Medicine 2020; 3(3): 264 doi: 10.1002/ame2.12133
|
| 75 |
Agata Mostkowska, Guy Rousseau, Noël J‐M Raynal. Repurposing of rituximab biosimilars to treat B cell mediated autoimmune diseases. The FASEB Journal 2024; 38(5) doi: 10.1096/fj.202302259RR
|
| 76 |
George Schatz, Erica Kumala, Amita Nathwani. A collaborative integrative and Ayurvedic approach to cirrhosis in the setting of autoantibody negative autoimmune hepatitis: a case report. Advances in Integrative Medicine 2022; 9(2): 136 doi: 10.1016/j.aimed.2021.10.002
|
| 77 |
André Jefremow, Markus F. Neurath. New agents for immunosuppression. Best Practice & Research Clinical Gastroenterology 2021; : 101763 doi: 10.1016/j.bpg.2021.101763
|
| 78 |
Kamil Janowski, Elizabeth Shumbayawonda, Andrea Dennis, Matt Kelly, Velicia Bachtiar, David DeBrota, Caitlin Langford, Helena Thomaides‐Brears, Maciej Pronicki, Wieslawa Grajkowska, Malgorzata Wozniak, Piotr Pawliszak, Sylwia Chełstowska, Elzbieta Jurkiewicz, Rajarshi Banerjee, Piotr Socha. Multiparametric MRI as a Noninvasive Monitoring Tool for Children With Autoimmune Hepatitis. Journal of Pediatric Gastroenterology and Nutrition 2021; 72(1): 108 doi: 10.1097/MPG.0000000000002930
|
| 79 |
Wei Zhang, Jung-hyun Rho, Michael H. Roehrl, Julia Y. Wang. A comprehensive autoantigen-ome of autoimmune liver diseases identified from dermatan sulfate affinity enrichment of liver tissue proteins. BMC Immunology 2019; 20(1) doi: 10.1186/s12865-019-0304-1
|
| 80 |
Christiane Sokollik, Valerie A. McLin, Diego Vergani, Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani. Juvenile autoimmune hepatitis: A comprehensive review. Journal of Autoimmunity 2018; 95: 69 doi: 10.1016/j.jaut.2018.10.007
|
| 81 |
|
| 82 |
Yuya Hirasawa, Kiyoshi Yoshimura, Hiroto Matsui, Yutaro Kubota, Hiroo Ishida, Jun Arai, Masashi Sakaki, Nao Oguro, Midori Shida, Makoto Taniguchi, Kazuyuki Hamada, Hirotsugu Ariizumi, Tomoyuki Ishiguro, Ryotaro Ohkuma, Takehiko Sambe, Atsushi Horiike, Chiyo K. Imamura, Eisuke Shiozawa, Satoshi Wada, Junji Tsurutani, Sanju Iwamoto, Naoki Uchida, Yuji Kiuchi, Genshu Tate, Shinichi Kobayashi, Takuya Tsunoda. A case report on severe nivolumab-induced adverse events similar to primary sclerosing cholangitis refractory to immunosuppressive therapy. Medicine 2021; 100(23): e25774 doi: 10.1097/MD.0000000000025774
|
| 83 |
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. Autoimmmune hepatitis. Cellular & Molecular Immunology 2022; 19(2): 158 doi: 10.1038/s41423-021-00768-8
|
| 84 |
Ansgar W. Lohse, Marcial Sebode, Mette Vesterhus. Reply to: “Both tacrolimus and mycophenylate mophetil should be considered second-line therapy for autoimmune hepatitis”. Journal of Hepatology 2021; 74(3): 755 doi: 10.1016/j.jhep.2020.11.031
|